In this study, the effect of cAMP- elevating agents on expression of p53 and BAD proteins as well as phoshorylated BAD protein was investigated in doxorubicin-treated pre-B ALL NALM-6 cell line. The gene discussed is BAD; the disease is acute lymphoblastic leukemia.